home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/580d822a-8eba-416c-844f-59d4a2c730f1_Diffucaps-Customized-Release-Technology-White-Paper.pdf
whitepaper
SHARESHARESHARE
FORMULATION CUSTOMIZATION: APPLYING DIFFUCAPS CUSTOMIZED RELEASE TECHNOLOGY TO REDUCE DOSING FREQUENCY AND ENCOURAGE PATIENT ADHERENCE
The pharmaceutical industry is driven to develop oral drug formulations that deliver significant patient benefits. Drug delivery technology can be leveraged to reduce dosing frequency, and therefore, help encourage patient adherence to prescribed therapeutic regimens. Benefits of successfully reducing dosing frequency Studies have shown a direct link between reduced dosing frequency and improved patient adherence.1 When patients are taking their medication more consistently, this can lead to a more successful course of treatment with positive outcomes. Several studies across various therapeutic categories have shown that once-daily (QD) dosing regimens can achieve equivalent efficacy, or even surpass the efficacy of their twice-daily (BID) or three-times-daily (TID) counterparts. DOWNLOAD